HK1204009A1 - Method of determining teratogenic risk - Google Patents
Method of determining teratogenic riskInfo
- Publication number
- HK1204009A1 HK1204009A1 HK15104695.3A HK15104695A HK1204009A1 HK 1204009 A1 HK1204009 A1 HK 1204009A1 HK 15104695 A HK15104695 A HK 15104695A HK 1204009 A1 HK1204009 A1 HK 1204009A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- determining
- teratogenic risk
- teratogenic
- risk
- determining teratogenic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261607622P | 2012-03-07 | 2012-03-07 | |
US201261668489P | 2012-07-06 | 2012-07-06 | |
PCT/EP2013/054244 WO2013131841A1 (en) | 2012-03-07 | 2013-03-04 | Method of determining teratogenic risk |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204009A1 true HK1204009A1 (en) | 2015-11-06 |
Family
ID=47827192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104695.3A HK1204009A1 (en) | 2012-03-07 | 2015-05-18 | Method of determining teratogenic risk |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150133340A1 (xx) |
EP (1) | EP2823036B1 (xx) |
JP (1) | JP6374324B2 (xx) |
KR (1) | KR20140142698A (xx) |
CN (1) | CN104160017B (xx) |
CA (1) | CA2860801A1 (xx) |
HK (1) | HK1204009A1 (xx) |
MX (1) | MX2014009132A (xx) |
RU (1) | RU2014139582A (xx) |
WO (1) | WO2013131841A1 (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800848B (zh) * | 2015-04-10 | 2018-10-16 | 首都儿科研究所 | 胸苷酸合成酶抑制剂在制备构建神经管畸形小鼠模型中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7541185B2 (en) * | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
CN109628371B (zh) * | 2003-12-23 | 2021-02-19 | 维亚希特公司 | 定形内胚层 |
US20090220996A1 (en) * | 2007-03-06 | 2009-09-03 | Reliance Life Sciences Pvt Ltd. | In vitro Assay Methods for Classifying Embryotoxicity of Compounds |
WO2008107912A2 (en) * | 2007-03-06 | 2008-09-12 | Reliance Life Sciences Pvt. Ltd. | In vitro assay methods for classifying embryotoxicity of compounds |
RU2555538C2 (ru) * | 2008-11-20 | 2015-07-10 | Сентокор Орто Байотек Инк. | Культура плюрипотентных стволовых клеток на микроносителях |
GB0911060D0 (en) * | 2009-06-26 | 2009-08-12 | Ge Healthcare Uk Ltd | Methods for predicting the toxicity of a chemical |
JP5814337B2 (ja) * | 2010-03-22 | 2015-11-17 | ステミナ バイオマーカー ディスカバリー, インコーポレイテッド | ヒト幹細胞様細胞及びメタボロミクスを使用した医薬のヒト発生毒性の予測 |
US8945847B2 (en) * | 2010-05-24 | 2015-02-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods and kits for ascertaining biosafety of an agent |
US9388388B2 (en) * | 2011-01-31 | 2016-07-12 | Katholieke Universiteit Leuven | Methods for making cells with an extra-embryonic endodermal precursor phenotype |
-
2013
- 2013-03-04 RU RU2014139582A patent/RU2014139582A/ru not_active Application Discontinuation
- 2013-03-04 US US14/381,430 patent/US20150133340A1/en not_active Abandoned
- 2013-03-04 WO PCT/EP2013/054244 patent/WO2013131841A1/en active Application Filing
- 2013-03-04 CN CN201380012437.0A patent/CN104160017B/zh not_active Expired - Fee Related
- 2013-03-04 JP JP2014560319A patent/JP6374324B2/ja not_active Expired - Fee Related
- 2013-03-04 MX MX2014009132A patent/MX2014009132A/es unknown
- 2013-03-04 KR KR1020147024825A patent/KR20140142698A/ko not_active Application Discontinuation
- 2013-03-04 CA CA2860801A patent/CA2860801A1/en not_active Abandoned
- 2013-03-04 EP EP13707618.8A patent/EP2823036B1/en active Active
-
2015
- 2015-05-18 HK HK15104695.3A patent/HK1204009A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2860801A1 (en) | 2013-09-12 |
RU2014139582A (ru) | 2016-04-27 |
EP2823036A1 (en) | 2015-01-14 |
CN104160017B (zh) | 2020-06-09 |
JP6374324B2 (ja) | 2018-08-15 |
KR20140142698A (ko) | 2014-12-12 |
MX2014009132A (es) | 2014-08-27 |
JP2015511005A (ja) | 2015-04-13 |
EP2823036B1 (en) | 2019-04-17 |
WO2013131841A1 (en) | 2013-09-12 |
CN104160017A (zh) | 2014-11-19 |
US20150133340A1 (en) | 2015-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201501833B (en) | Method for obtaining 1-kestone | |
PL2825719T3 (pl) | Sposób obsługi odwiertów | |
GB201223172D0 (en) | Method | |
GB201212937D0 (en) | Method | |
GB201212932D0 (en) | Method | |
GB201213636D0 (en) | Method | |
GB201212934D0 (en) | Method | |
GB201210858D0 (en) | Method | |
BR112014025875A2 (pt) | Método de medição | |
PL2864585T3 (pl) | Sposób usuwania nieorganicznych osadów | |
GB201220155D0 (en) | Method of manufacture | |
GB201218570D0 (en) | Method | |
EP2880048A4 (en) | METHOD | |
GB201202198D0 (en) | Method | |
GB201211393D0 (en) | Method | |
GB201215942D0 (en) | Method of treatent | |
HK1204009A1 (en) | Method of determining teratogenic risk | |
GB201222737D0 (en) | Method | |
GB201217688D0 (en) | Method | |
GB201214029D0 (en) | method | |
GB201210147D0 (en) | Method | |
GB201301405D0 (en) | Analytical Method | |
GB201213858D0 (en) | Method | |
GB201203337D0 (en) | Method | |
GB201201332D0 (en) | Method |